ZA979060B - Receptor selective BNP - Google Patents

Receptor selective BNP

Info

Publication number
ZA979060B
ZA979060B ZA979060A ZA979060A ZA979060B ZA 979060 B ZA979060 B ZA 979060B ZA 979060 A ZA979060 A ZA 979060A ZA 979060 A ZA979060 A ZA 979060A ZA 979060 B ZA979060 B ZA 979060B
Authority
ZA
South Africa
Prior art keywords
bnp
receptor selective
receptor
selective
selective bnp
Prior art date
Application number
ZA979060A
Other languages
English (en)
Inventor
David G Lowe
Jill R Schoenfeld
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ZA979060B publication Critical patent/ZA979060B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/58Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA979060A 1996-10-22 1997-10-09 Receptor selective BNP ZA979060B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73188096A 1996-10-22 1996-10-22

Publications (1)

Publication Number Publication Date
ZA979060B true ZA979060B (en) 1999-04-09

Family

ID=24941306

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA979060A ZA979060B (en) 1996-10-22 1997-10-09 Receptor selective BNP

Country Status (6)

Country Link
EP (1) EP0939770A1 (ja)
JP (1) JP2001503256A (ja)
AU (1) AU4816497A (ja)
CA (1) CA2269656A1 (ja)
WO (1) WO1998017690A1 (ja)
ZA (1) ZA979060B (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG159387A1 (en) 2002-11-26 2010-03-30 Biocon Ltd In Modified natriuretic compounds, conjugates, and uses thereof
PL2348114T3 (pl) 2004-04-21 2019-08-30 Alexion Pharmaceuticals, Inc. Koniugaty do dostarczania do kości i sposób ich wykorzystania do nakierowywania białek na kość
AU2011350066A1 (en) 2010-12-27 2013-07-11 Alexion Pharma International Sarl Compositions comprising natriuretic peptides and methods of use thereof
US10052366B2 (en) 2012-05-21 2018-08-21 Alexion Pharmaceuticsl, Inc. Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
WO2016007873A1 (en) 2014-07-11 2016-01-14 The Regents Of The University Of Michigan Compositions and methods for treating craniosynostosis
CN107405390A (zh) 2014-12-05 2017-11-28 阿雷克森制药公司 用重组碱性磷酸酶治疗癫痫
CA2973883A1 (en) 2015-01-28 2016-08-04 Alexion Pharmaceuticals, Inc. Methods of treating a subject with an alkaline phosphatase deficiency
WO2017031114A1 (en) 2015-08-17 2017-02-23 Alexion Pharmaceuticals, Inc. Manufacturing of alkaline phosphatases
EP3355904A4 (en) 2015-09-28 2019-06-12 Alexion Pharmaceuticals, Inc. IDENTIFICATION OF EFFECTIVE DOSE SHEETS FOR TISSUE-SPECIFIC ALKALINE PHOSPHATASE ENZYMERSAT THERAPY OF HYPOPHOSPHATASIA
WO2017074466A1 (en) 2015-10-30 2017-05-04 Alexion Pharmaceuticals, Inc. Methods for treating craniosynostosis in a patient
US11065306B2 (en) 2016-03-08 2021-07-20 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in children
EP3436052A4 (en) 2016-04-01 2019-10-09 Alexion Pharmaceuticals, Inc. TREATMENT OF MUSCLE WEAKNESS USING ALKALINE PHOSPHATASES
WO2017173395A1 (en) 2016-04-01 2017-10-05 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in adolescents and adults
EP3464573A4 (en) 2016-06-06 2020-02-19 Alexion Pharmaceuticals, Inc. IMPACT OF METAL ON THE PRODUCTION OF ALKALINE PHOSPHATASES
WO2018035420A1 (en) 2016-08-18 2018-02-22 Alexion Pharmaceuticals, Inc. Methods for treating tracheobronchomalacia
BR112019020506A2 (pt) 2017-03-31 2020-08-04 Alexion Pharmaceuticals, Inc. métodos para o tratamento de hipofosfatasia (hpp) em adultos e adolescentes
EP3773684A1 (en) 2018-03-30 2021-02-17 Alexion Pharmaceuticals, Inc. Manufacturing of glycoproteins
BR112023016048A2 (pt) 2021-02-12 2023-11-14 Alexion Pharma Inc Polipeptídeos de fosfatase alcalina e métodos de uso dos mesmos

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69432123T2 (de) * 1993-11-12 2004-01-08 Genentech, Inc., South San Francisco Rezeptor spezifische atrio-natriuretische peptide

Also Published As

Publication number Publication date
WO1998017690A1 (en) 1998-04-30
JP2001503256A (ja) 2001-03-13
AU4816497A (en) 1998-05-15
EP0939770A1 (en) 1999-09-08
CA2269656A1 (en) 1998-04-30

Similar Documents

Publication Publication Date Title
IL127666A0 (en) IL-8 receptor antagonists
HUP9903922A3 (en) Il-8 receptor antagonists
HU9603525D0 (en) Vironectin receptor antagonists
EP0932405A4 (en) IL-8 RECEPTOR ANTAGONISTS
EP1007563A4 (en) HM74A RECEPTOR
IL128501A0 (en) IL-8 receptor antagonists
ZA979060B (en) Receptor selective BNP
EP1019035A4 (en) IL-8 RECEPTOR ANTAGONISTS
EP0907362A4 (en) IL-8 RECEPTOR ANTAGONISTS
EP0920417A4 (en) IL-8 RECEPTOR ANTAGONISTS
IL133920A0 (en) Trail receptor
EP0929218A4 (en) R2Y RECEPTOR ANTAGONISTS
GB9617923D0 (en) Novel receptor
PL318894A1 (en) Roof structure
EP0923373A4 (en) IL-8 RECEPTOR ANTAGOISTS
EP1084142A4 (en) GPR35A RECEIVER
EP0939634A4 (en) IL-8 RECEPTOR ANTAGONISTS
EP0973800A4 (en) NEW RECEIVER
EP0934066A4 (en) IL-8 RECEPTOR ANTAGONISTS
EP0920253A4 (en) IL-8 RECEPTOR ANTAGONISTS
EP0948330A4 (en) COOLING ANTENNA WITH CURVED SEGMENTS
GB2315286B (en) Structure
EP1083909A4 (en) hCEPR RECEPTOR
EP0859787A4 (en) G PROTEIN COUPLED RECEPTOR HNFD578
EP1109565A4 (en) GABAB1AA RECEPTOR